residu
surround
chlorid
ion
site
tace
shown
fig
tace
residu
coordin
chlorid
ion
site
conserv
residu
influenc
chlorid
bind
therefor
chlorid
sensit
enzym
activ
equival
tace
residu
also
implic
chlorid
sensit
close
proxim
chlorid
ion
also
lie
two
residu
upstream
known
critic
substrat
bind
site
chlorid
tace
bound
water
molecul
correspond
residu
sace
previous
shown
mutant
serv
vital
role
chlorid
depend
equival
residu
tace
pcr
mutagenesi
employ
tace
site
residu
describ
list
tabl
order
investig
role
chlorid
sensit
tace
tripl
mutant
also
construct
determin
whether
synergist
effect
chlorid
sensit
occur
stabl
express
tace
mutant
establish
cell
shown
compar
form
mutant
protein
also
migrat
appar
r
enzym
fig
consequ
differ
observ
activ
level
enzym
variant
attribut
signific
alter
protein
express
angiotensin
substrat
mm
nacl
physiolog
concentr
chlorid
ion
human
plasma
mutant
vari
degre
level
activ
less
tace
mutant
contain
site
mutat
lowest
level
activ
tace
possess
rel
activ
respect
contrast
tace
equival
variant
mutant
lowest
rel
activ
tabl
rate
angiotensin
ii
cleavag
also
record
mm
nacl
variant
tabl
physiolog
substrat
enzym
surprisingli
site
mutant
tripl
mutant
show
enhanc
level
angiotensin
ii
cleavag
compar
physiolog
concentr
chlorid
possess
rel
activ
respect
result
strongli
suggest
contribut
substrat
select
enzym
particularli
higher
level
activ
angiotensin
ii
hydrolysi
angiotensin
wherea
differ
observ
follow
remov
chlorid
ion
extens
dialysi
effect
increas
chlorid
concentr
activ
tace
observ
fig
report
previous
angiotensin
cleavag
tace
activ
chlorid
ion
activ
profil
differ
howev
two
enzym
tace
activ
continu
increas
nacl
increas
fig
wherea
maxim
activ
obtain
approxim
mm
nacl
fig
degre
chlorid
activ
angiotensin
hydrolysi
greater
tace
increas
level
activ
record
mm
nacl
compar
mm
tace
wherea
increas
activ
occur
effect
increas
chlorid
concentr
rate
cleavag
angiotensin
ii
distinct
complex
angiotensin
fig
twofold
increas
activ
observ
nacl
increas
mm
increas
chlorid
concentr
produc
inhibitori
effect
activ
plateau
reach
mm
nacl
consequ
level
activ
mm
nacl
less
absenc
nacl
less
mm
nacl
order
observ
effect
variou
mutat
chlorid
sensit
tace
fold
differ
activ
mm
nacl
angiotensin
mm
nacl
angiotensin
ii
record
fig
concentr
chosen
allow
elucid
maxim
level
chlorid
activ
intriguingli
tace
show
inhibit
angiotensin
cleavag
induc
mm
nacl
correspond
fold
differ
activ
compar
differ
record
fig
site
site
mutat
also
show
pronounc
effect
signific
chlorid
sensit
observ
either
variant
mutant
behav
similar
manner
two
mutant
also
lack
chlorid
sensit
show
increas
angiotensin
cleavag
mm
nacl
variant
possess
significantli
lower
level
chlorid
activ
substrat
exhibit
increas
activ
respect
fig
show
increas
activ
chlorid
sensit
enzym
similar
variant
addit
found
lack
signific
chlorid
sensit
substrat
show
activ
absenc
chlorid
ion
angiotensin
ii
serv
substrat
promin
differ
observ
sever
variant
lack
signific
level
chlorid
sensit
fig
mutant
alreadi
identifi
possess
greater
level
activ
substrat
mm
nacl
tabl
even
pronounc
illustr
fig
absenc
chlorid
ion
greater
level
activ
substrat
angiotensin
chlorid
sensit
variant
angiotensin
ii
similar
variant
show
elev
level
angiotensin
ii
cleavag
decreas
level
angiotensin
cleavag
compar
physiolog
nacl
concentr
investig
alter
substrat
select
variant
kinet
paramet
k
v
max
cleavag
angiotensin
ii
mm
nacl
elucid
tabl
found
signific
differ
k
valu
two
variant
v
max
higher
catalyt
effici
v
maxk
also
greater
condit
data
indic
mutat
increas
angiotensin
ii
hydrolysi
enhanc
maxim
level
activ
alter
affin
shown
previous
potenc
ace
inhibit
captopril
lisinopril
enalaprilat
enhanc
nacl
increas
howev
previou
report
chlorid
sensit
potenc
inhibitor
henc
curv
obtain
inhibit
variant
inhibit
tace
variant
captopril
absenc
presenc
nacl
mm
valu
deriv
curv
show
inhibit
sensit
chlorid
concentr
observ
tace
fig
valu
record
mm
nacl
lower
absenc
chlorid
ion
captopril
valu
tace
decreas
mm
nacl
chlorid
sensit
inhibitor
potenc
lack
tace
fig
agreement
absenc
chlorid
sensit
angiotensin
cleavag
variant
fig
variant
valu
greater
record
absenc
presenc
mm
nacl
respect
fig
similarli
variant
valu
greater
absenc
presenc
mm
nacl
respect
therefor
clear
two
mutat
reduc
potenc
find
studi
provid
support
physiolog
relev
chlorid
sensit
ace
activ
confirm
increas
mm
physiolog
concentr
human
plasma
increas
angiotensin
decreas
angiotensin
ii
cleavag
increas
angiotensin
cleavag
ace
would
effect
increas
local
concentr
vasoconstrictor
angiotensin
ii
decreas
would
lead
opposit
scenario
reduc
local
angiotensin
ii
concentr
high
level
ace
kidney
expos
enzym
fluctuat
occur
plasma
therefor
vivo
sensit
may
serv
regul
local
concentr
angiotensin
peptid
particularli
kidney
thu
act
homeostat
regulatori
mechan
format
tace
mutant
sever
site
residu
critic
chlorid
sensit
activ
identifi
first
time
tace
equival
residu
coordin
chlorid
ion
site
ionic
interact
remov
interact
mutagenesi
abolish
greatli
reduc
level
chlorid
sensit
locat
close
proxim
chlorid
ion
site
lie
two
residu
upstream
known
critic
substrat
bind
mutagenesi
tace
equival
also
identifi
residu
critic
chlorid
sensit
two
enzym
site
unlik
influenc
zinc
bind
ion
tace
howev
suggest
import
stabil
complex
format
residu
subdomain
ii
involv
directli
substrat
bind
site
ace
previous
suggest
contain
mechanist
bind
chlorid
ion
bound
enzym
break
salt
bridg
sace
facilit
movement
toward
activ
site
found
studi
tace
site
mutant
possess
signific
chlorid
sensit
predict
previou
studi
equival
sace
mutant
consequ
critic
chlorid
depend
tace
sace
crystal
structur
tace
reveal
combin
water
molecul
bind
chlorid
ion
site
ionic
interact
residu
chlorid
ion
therefor
essenti
chlorid
sensit
mediat
site
although
site
chlorid
absent
variant
affect
chlorid
sensit
enzym
observ
increas
activ
twofold
less
angiotensin
absent
angiotensin
ii
would
thu
appear
mutat
abl
transmit
effect
chlorid
sensit
enzym
induc
site
chlorid
sensit
tace
tripl
mutant
consist
found
similar
tace
respect
suggest
greatest
influenc
chlorid
regul
activ
site
ace
inde
contain
mechanist
bind
chlorid
ion
site
residu
strongli
influenc
substrat
select
remov
posit
charg
residu
creation
mutant
produc
enzym
compar
show
twofold
greater
activ
substrat
angiotensin
ii
twofold
less
activ
angiotensin
physiolog
nacl
crystal
structur
reveal
topolog
chemic
environ
subsit
dictat
four
residu
expect
restrict
size
substrat
therefor
mutat
probabl
alter
environ
subsit
make
favour
angiotensin
ii
hydrolysi
less
favour
angiotensin
hydrolysi
kinet
data
confirm
variant
threefold
greater
catalyt
effici
angiotensin
ii
result
alter
affin
increas
v
max
variant
variant
enhanc
activ
toward
angiotensin
ii
potenti
therapeut
valu
acut
lung
injuri
mice
suffer
condit
previous
shown
markedli
improv
diseas
follow
inject
recombin
abdomen
studi
potenc
tace
inhibitor
discov
chlorid
sensit
high
increas
inhibitor
potenc
believ
occur
result
facilit
inhibitor
bind
conform
chang
induc
chlorid
bind
intriguingli
contrast
find
potenc
ace
inhibitor
known
increas
rat
subject
diet
therefor
appar
addit
mechan
vivo
influenc
ace
inhibitor
potenc
overrid
chlorid
alter
ace
inhibitor
potenc
observ
residu
identifi
critic
potenc
mutat
drastic
reduc
valu
record
comparison
locat
next
subsit
mutat
hypothes
alter
environ
region
one
less
accommod
bind
approxim
dichlorobenzyl
group
unlik
directli
hinder
inhibitor
bind
probabl
explan
mutat
transmit
conform
chang
activ
site
long
distanc
make
environ
bind
less
favour
peptid
angiotensin
angiotensin
ii
obtain
bachem
intern
st
helen
uk
fluorogen
peptid
dnp
dnp
abz
acid
obtain
biomol
intern
exet
uk
tace
cdna
contain
nucleotid
provid
e
parkin
univers
leed
uk
cdna
contain
nucleotid
encod
truncat
protein
lack
transmembran
cytosol
domain
provid
j
l
guy
univers
leed
uk
mutagen
pcr
carri
ml
eppendorf
tube
reaction
volum
describ
previous
plasmid
dna
prepar
singl
coloni
fulli
sequenc
ensur
presenc
desir
point
mutat
absenc
unintend
mutat
cell
cultur
atmospher
dmem
grown
approxim
confluenc
petri
dish
immedi
prior
transfect
plasmid
dna
cell
monolay
wash
twice
naclpi
genejuic
transfect
reagent
use
ratio
dna
reagent
wv
ad
petri
dish
ml
dmem
incub
h
addit
supplement
dmem
h
transfect
cell
passag
allow
grow
supplement
medium
contain
antibiot
cell
subject
repeat
round
select
reach
confluenc
passag
allow
continu
grow
select
medium
collect
solubl
secret
protein
cell
incub
ml
optimem
h
harvest
sampl
concentr
use
centricon
millipor
billerica
usa
kda
filter
unit
tace
protein
obtain
follow
medium
remov
wash
cell
three
time
naclpi
scrape
ml
naclpi
chlorid
activ
assay
sampl
exchang
mm
hepeskoh
ph
use
centricon
kda
filter
unit
total
rna
isol
cell
use
rneasi
mini
kit
valencia
ca
usa
accord
manufactur
guidelin
carri
use
kit
bd
bioscienc
san
jose
ca
usa
accord
manufactur
guidelin
follow
pcr
profil
use
one
cycl
h
one
cycl
min
cycl
min
one
cycl
min
amplicon
sequenc
confirm
integr
product
process
carri
mutant
variant
protein
concentr
determin
use
bicinchonin
acid
assay
bovin
serum
albumin
standard
protein
sampl
prepar
gel
load
buffer
sigma
pool
uk
heat
min
sampl
separ
use
method
describ
laemmli
polyacrylamid
run
gel
polyacrylamid
stack
gel
prestain
protein
standard
run
alongsid
sampl
protein
electrophoret
transfer
poli
vinyliden
difluorid
membran
polyacrylamid
gel
membran
satur
nacltri
mm
trishcl
ph
mm
nacl
contain
wv
nonfat
milk
h
tace
detect
membran
incub
overnight
mous
monoclon
ace
ectodomain
igg
obtain
r
system
europ
ltd
abingdon
uk
wv
bovin
serum
albumin
nacltri
contain
vv
tween
tbst
rins
tbst
membran
wash
three
time
tbst
min
room
temperatur
membran
incub
h
room
temperatur
horseradish
igg
obtain
sigma
tbst
tbst
wash
repeat
visual
immunoreact
protein
chemiluminesc
use
ecl
kit
ident
method
detect
employ
except
primari
antibodi
goat
polyclon
ectodomain
igg
obtain
r
system
secondari
antibodi
horseradish
igg
obtain
sigma
activ
assay
carri
mm
hepe
buffer
ph
contain
state
concentr
nacl
final
volum
specif
activ
determin
protein
either
captopril
inhibitor
nm
inhibitor
min
addit
angiotensin
angiotensin
ii
reaction
carri
h
termin
heat
min
condit
ensur
product
format
linear
respect
time
amount
protein
aliquot
assay
solut
appli
hplc
column
particl
size
mm
intern
diamet
phenomenex
cheshir
uk
uv
detector
set
nm
separ
carri
room
temperatur
flow
rate
mobil
phase
consist
vv
trifluoroacet
acid
water
mobil
phase
b
consist
vv
trifluoroacet
acid
acetonitril
linear
gradient
b
b
min
min
final
condit
min
use
elut
posit
product
determin
use
pure
synthet
standard
k
v
max
valu
determin
describ
except
six
concentr
angiotensin
ii
rang
incub
variou
form
tace
enzym
concentr
adjust
ensur
substrat
consum
lowest
substrat
concentr
guarante
product
format
linear
respect
time
durat
assay
k
v
max
valu
calcul
linear
regress
use
equat
v
v
max
k
valu
inhibit
variant
determin
describ
previous
valu
captopril
inhibit
tace
variant
determin
similar
manner
except
dnp
serv
substrat
